These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 19222434
1. Goodbye suxamethonium! Lee C. Anaesthesia; 2009 Mar; 64 Suppl 1():73-81. PubMed ID: 19222434 [Abstract] [Full Text] [Related]
2. Suxamethonium stands the test of time: it is too early to say goodbye. Umesh G, Jasvinder K, Shetty N. Anaesthesia; 2009 Sep; 64(9):1023; author reply 1023-4. PubMed ID: 19686492 [No Abstract] [Full Text] [Related]
4. Twitch augmentation and train-of-four fade during onset of neuromuscular block after subclinical doses of suxamethonium. Kim SY, Lee JS, Kim SC, Park W. Br J Anaesth; 1997 Sep; 79(3):379-81. PubMed ID: 9389859 [Abstract] [Full Text] [Related]
5. The place of suxamethonium in pediatric anesthesia. Rawicz M, Brandom BW, Wolf A. Paediatr Anaesth; 2009 Jun; 19(6):561-70. PubMed ID: 19645973 [Abstract] [Full Text] [Related]
6. Are fade and sustained post-tetanic facilitation characteristics of typical succinylcholine-induced block? Naguib M. Br J Anaesth; 2001 Sep; 87(3):522-4. PubMed ID: 11556294 [No Abstract] [Full Text] [Related]
7. Clinical implications of sugammadex. Caldwell JE, Miller RD. Anaesthesia; 2009 Mar; 64 Suppl 1():66-72. PubMed ID: 19222433 [Abstract] [Full Text] [Related]
8. Changes in plasma potassium and neuromuscular blockade following suxamethonium in patients pre-treated with terbutaline. Slater RM, From RP, Sum Ping JS, Pank JR. Eur J Anaesthesiol; 1991 Jul; 8(4):281-6. PubMed ID: 1651859 [Abstract] [Full Text] [Related]
9. [The effect of suxamethonium on intracranial pressure]. Handberg G, Jeppesen IS, Frederiksen HJ, Madsen JB. Ugeskr Laeger; 1996 Apr 22; 158(17):2381-3. PubMed ID: 8685991 [Abstract] [Full Text] [Related]
10. Neuromuscular blocking drugs and their antagonists in patients with organ disease. Craig RG, Hunter JM. Anaesthesia; 2009 Mar 22; 64 Suppl 1():55-65. PubMed ID: 19222432 [Abstract] [Full Text] [Related]
11. In vivo animal studies with sugammadex. Booij LH, van Egmond J, Driessen JJ, de Boer HD. Anaesthesia; 2009 Mar 22; 64 Suppl 1():38-44. PubMed ID: 19222430 [Abstract] [Full Text] [Related]
12. Preclinical pharmacology of sugammadex. Bom A, Hope F, Rutherford S, Thomson K. J Crit Care; 2009 Mar 22; 24(1):29-35. PubMed ID: 19272536 [Abstract] [Full Text] [Related]
14. The nature of suxamethonium neuromuscular block in the dog assessed by train-of-four stimulation. Cullen LK, Jones RS. Res Vet Sci; 1980 Nov 22; 29(3):281-8. PubMed ID: 7255890 [Abstract] [Full Text] [Related]
15. The neuromuscular blocking action of suxamethonium following intravenous and intramuscular administration. Schuh FT. Int J Clin Pharmacol Ther Toxicol; 1982 Sep 22; 20(9):399-403. PubMed ID: 7141759 [Abstract] [Full Text] [Related]
19. Effects of succinylcholine on the recovery of block produced by mivacurium in rats. Kanyamibwa D, Tsaousi G, Karakoulas K, Thomareis O, Parlapani A, Makedou AH, Giala M. Methods Find Exp Clin Pharmacol; 2008 Apr 22; 30(3):187-91. PubMed ID: 18597002 [Abstract] [Full Text] [Related]
20. The effect of neostigmine on suxamethonium induced neuromuscular block in the dog. Cullen LK, Jones RS. Res Vet Sci; 1980 Sep 22; 29(2):266-8. PubMed ID: 7466001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]